France· FR:68778431
NOVOFEMME, comprimé pelliculé
A medicinal product containing acétate de noréthistérone + estradiol hémihydraté, registered in France by NOVO NORDISK, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACÉTATE DE NORÉTHISTÉRONE + ESTRADIOL HÉMIHYDRATÉ
- Manufacturer
- NOVO NORDISK
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009358479281 boîte(s) avec distributeur(s) polypropylène polystyrène de 16 comprimé(s) rouges et de 12 comprimé(s) blancsEUR 6.25
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acétate de noréthistérone + estradiol hémihydraté in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandActivelleParanova Oy
- CzechiaACTIVELLENovo Nordisk A/S, Bagsvaerd
- SwedenFemanor TablettExeltis Healthcare, S.L.
- IrelandEvorel Conti 50/170 micrograms per 24 hours Transdermal PatchTheramex Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Germany · Estramon Comp, Estramon Conti
- Denmark · Evo Conti, Evo-Sequi
- Finland · Evorel Conti, Evorel Sequi
- United Kingdom (Northern Ireland) · Elleste
- Ireland · Evorel Conti
- Iceland · Femanor, Femasekvens
- Liechtenstein · Systen Sequi
- Poland · Activelle, Systen Conti
- Sweden · Femanor, Femasekvens
- Slovenia · Trisequens
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6001460-d886-438c-9cbd-057f464cd439 GET /v1/drugs/f6001460-d886-438c-9cbd-057f464cd439?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68778431",
"date_amm": "2002-01-18",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "ACÉTATE DE NORÉTHISTÉRONE + ESTRADIOL HÉMIHYDRATÉ",
"statut_amm": "Autorisation archivée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "comprimé pelliculé et comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about acétate de noréthistérone + estradiol hémihydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.